Zobrazeno 1 - 10
of 32
pro vyhledávání: '"M, Aldouri"'
Autor:
M. Aldouri, Ke Lin, C. Murphy, Christopher P. Fox, Geetha Menon, Shankara Paneesha, Melanie Oates, Sarah E. Coupland, Peter Hillmen, Nagesh Kalakonda, Deborah Turner, S. Jenkins, F. Wandroo, P. Cervi, Anna Schuh, Saad M. B. Rassam, Andrew S Duncombe, Michael R. Hamblin, Silvia Cicconi, Christopher Pocock, C. Knechtli, Andrew R. Pettitt
Publikováno v:
Hematological Oncology. 37:217-218
Autor:
Andrew R. Pettitt, Deborah Turner, Anna Schuh, Melanie Oates, Saad M. B. Rassam, Christopher Pocock, Christopher P. Fox, Nagesh Kalakonda, Fotis Polydoros, Peter Hillmen, Geetha Menon, S. Jenkins, Sarah E. Coupland, P. Cervi, C. Knechtli, Ke Lin, Michael R. Hamblin, Andrew S Duncombe, M. Jenner, Matthew Bickerstaff, Shankara Paneesha, M. Aldouri, F. Wandroo
Publikováno v:
Hematological Oncology. 35:88-89
Autor:
K. Saunders, Mallika Sekhar, Ghulam J. Mufti, J.P.L.A. Hayes, Aloysius Ho, B. Czepulkowski, R. Sivalingam, M. Cummins, M. Aldouri
Publikováno v:
Cancer Genetics and Cytogenetics. 156:154-157
Interstitial deletion of the long arm of chromosome 20, as the sole abnormality, is commonly observed in myeloid malignancies, including myeloproliferative disorder, myelodysplastic syndrome, and acute myeloid leukemia. The breakpoints of the deletio
Autor:
Bob, Löwenberg, Joachim, Beck, Carlos, Graux, Wim, van Putten, Harry C, Schouten, Leo F, Verdonck, Augustin, Ferrant, Pieter, Sonneveld, Mojca, Jongen-Lavrencic, Marie, von Lilienfeld-Toal, Bart J, Biemond, Edo, Vellenga, Dimitri, Breems, Hilde, de Muijnck, Ron, Schaafsma, Gregor, Verhoef, Hartmut, Döhner, Alois, Gratwohl, Thomas, Pabst, Gert J, Ossenkoppele, Johan, Maertens, M, Aldouri
Publikováno v:
Lowenberg, B, Beck, J, Graux, C, van Putten, W, Schouten, H C, Verdonck, L F, Ferrant, A, Sonneveld, P, Jongen-Lavrencic, M, von Lilienfeld-Toal, M, Biemond, B J, Vellenga, E, Breems, D, de Muijnck, H, Schaafsma, R, Verhoef, G, Dohner, H, Gratwohl, A, Pabst, T, Ossenkoppele, G J & Maertens, J 2010, ' Gemtuzumab ozogamicin as postremission treatment in AML at 60 years of age or more: results of a multicenter phase 3 study ', Blood, vol. 115, no. 13, pp. 2586-2591 . https://doi.org/10.1182/blood-2009-10-246470
Blood, 115(13), 2586-2591. American Society of Hematology
Blood, 115(13), 2586-2591. The American Society of Hematology
Blood, 115(13), 2586-2591. AMER SOC HEMATOLOGY
Blood, 115(13), 2586-2591. American Society of Hematology
Blood, 115(13), 2586-2591. The American Society of Hematology
Blood, 115(13), 2586-2591. AMER SOC HEMATOLOGY
In older patients with acute myeloid leukemia (AML), the prevention of relapse has remained one of the major therapeutic challenges, with more than 75% relapses after complete remission. The anti-CD33 immunotoxin conjugate gemtuzumab ozogamicin (GO)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab53eeabda328b5ebb52f93ca892bde4
https://research.vumc.nl/en/publications/1eda5722-d7c0-4e11-9e4d-65b71fcd5abf
https://research.vumc.nl/en/publications/1eda5722-d7c0-4e11-9e4d-65b71fcd5abf
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Cancer genetics and cytogenetics. 151(2)
Deletion of the long arm of chromosome 15 has been described as a recurrent chromosomal abnormality in myeloid malignancies. We present here some additional case reports of deletion 15 including two cases with an extra copy of the deleted chromosome,
Publikováno v:
Bone Marrow Transplantation. 38:461-462
Prolonged remission in a case of Richter's transformation of B-cell chronic lymphocytic leukaemia following adoptive immunotherapy
Publikováno v:
Clinical Lymphoma and Myeloma. 9:S37
Publikováno v:
Qatar Medical Journal. 1997:11
A 38-year-old female patient, known to have widespread adenocarcinoma of an unknown primary, presented with galactorrhoea and amenorrhoea for a few months. The serum prolactin level was markedly elevated (more than 20-fold the upper normal limit). A